These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8606265)

  • 1. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes.
    Aoki I; Shimoyama K; Aoki N; Homori M; Yanagisawa A; Nakahara K; Kawai Y; Kitamura SI; Ishikawa K
    J Am Coll Cardiol; 1996 Mar; 27(3):560-6. PubMed ID: 8606265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-dependent thrombin generation in patients with hyperlipidemia.
    Aoki I; Aoki N; Kawano K; Shimoyama K; Maki A; Homori M; Yanagisawa A; Yamamoto M; Kawai Y; Ishikawa K
    J Am Coll Cardiol; 1997 Jul; 30(1):91-6. PubMed ID: 9207626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet sodium-proton exchanger and phospholipid-dependent procoagulant activity in patients with type 2 diabetes.
    Telejko B; Tomasiak M; Stelmach H; Kinalska I
    Metabolism; 2003 Jan; 52(1):102-6. PubMed ID: 12524669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors influencing platelet procoagulant activity in type II diabetic patients. The role of sodium-proton exchange].
    Telejko B; Kinalska I; Stelmach H; Tomasiak M
    Przegl Lek; 2003; 60(9):553-6. PubMed ID: 15065331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet free Ca2+ concentration in non-insulin-dependent diabetes mellitus.
    Yamaguchi T; Kadono K; Tetsutani T; Yasunaga K
    Diabetes Res; 1991 Oct; 18(2):89-94. PubMed ID: 1841817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation.
    Gajos G; Siniarski A; Natorska J; Ząbczyk M; Siudut J; Malinowski KP; Gołębiowska-Wiatrak R; Rostoff P; Undas A
    Cardiovasc Diabetol; 2018 Nov; 17(1):146. PubMed ID: 30466424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
    Kohlmorgen C; Gerfer S; Feldmann K; Twarock S; Hartwig S; Lehr S; Klier M; Krüger I; Helten C; Keul P; Kahl S; Polzin A; Elvers M; Flögel U; Kelm M; Levkau B; Roden M; Fischer JW; Grandoch M
    Diabetologia; 2021 Aug; 64(8):1834-1849. PubMed ID: 34131781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intracellular calcium mobilization in platelets from patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Ishii H; Umeda F; Hashimoto T; Nawata H
    Diabetologia; 1991 May; 34(5):332-6. PubMed ID: 1907585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus.
    Udvardy M; Posan E; Harsfalvi J
    Thromb Res; 1995 Jul; 79(1):57-63. PubMed ID: 7495104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR-4/Ca
    Giannella A; Ceolotto G; Radu CM; Cattelan A; Iori E; Benetti A; Fabris F; Simioni P; Avogaro A; Vigili de Kreutzenberg S
    Cardiovasc Diabetol; 2021 Apr; 20(1):77. PubMed ID: 33812377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.
    Gajos G; Konieczynska M; Zalewski J; Undas A
    Cardiovasc Diabetol; 2015 May; 14():44. PubMed ID: 25928628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Only minor changes in thrombin generation of children and adolescents with type 1 diabetes mellitus - A case-control study.
    Cimenti C; Schlagenhauf A; Leschnik B; Fröhlich-Reiterer E; Jasser-Nitsche H; Haidl H; Suppan E; Weinhandl G; Leberl M; Borkenstein M; Muntean WE
    Thromb Res; 2016 Dec; 148():45-49. PubMed ID: 27776253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting.
    Lee S; Ay C; Kopp CW; Panzer S; Gremmel T
    Cardiovasc Diabetol; 2018 Sep; 17(1):131. PubMed ID: 30268122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
    Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
    Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of thrombin generation and platelet secretion in diabetes mellitus.
    Rosove MH; Berliner JA; Harwig SS; Frank HJ
    Diabetes Res; 1985 Jul; 2(4):171-3. PubMed ID: 2935351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy.
    van der Planken MG; Vertessen FJ; Vertommen J; Engelen W; Berneman ZN; De Leeuw I
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):65-8. PubMed ID: 10775023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.
    Li Y; Woo V; Bose R
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1480-9. PubMed ID: 11247757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.